Buch, Englisch, Band 433, 130 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 224 g
Buch, Englisch, Band 433, 130 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 224 g
Reihe: Current Topics in Microbiology and Immunology
ISBN: 978-3-030-85069-2
Verlag: Springer International Publishing
This book introduces nanoparticles as a powerful platform for vaccine design. Current challenges in vaccine development are discussed and the unique advantages nanoparticles provide in overcoming these challenges are explored. The authors offer fascinating insights into the immunological assets of using nanoparticles as delivery vehicles or adjuvants and present different materials that are being used in nanoparticle-based vaccine development, covering peptides, proteins, polymers, virus-like particles, and liposomes.
Its contemporary research insights and practical examples for applications make this volume an inspiring read for researchers and clinicians in vaccinology and immunology.
Chapter "Liposome Formulations as Adjuvants for Vaccines" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Naturwissenschaften Biowissenschaften Virologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Medizinische Mikrobiologie & Virologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Physiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Naturwissenschaften Chemie Physikalische Chemie Molekulare Chemische Nanostrukturen
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
Weitere Infos & Material
Preface.- Liposome Formulations as Adjuvants for Vaccines.- Polymeric nanoparticle-based vaccine adjuvants and delivery vehicles.- Virus-like particle vaccines against respiratory viruses and protozoan parasites.- Protein and Peptide Nanocluster Vaccines.